• 1. Carboxylate isosteres for caspase inhibitors: the acylsulfonamide case revisited
  Y. Adriaenssens,D. Jiménez Fernández,L. Vande Walle,F. Elvas,J. Joossens,A. Lambeir,K. Augustyns,M. Lamkanfi,P. Van der Veken Org. Biomol. Chem. 2017 15 7456
• 2. Can solvated intermediates inform us about nucleation pathways? The case of β-pABA
  A. J. Cruz-Cabeza,E. Taylor,I. J. Sugden,D. H. Bowskill,S. E. Wright,H. Abdullahi,D. Tulegenov,G. Sadiq,R. J. Davey CrystEngComm 2020 22 7447
• 3. De novo biosynthesis and whole-cell catalytic production of paracetamol on a gram scale in Escherichia coli
  Feifei Hou,Mo Xian,Wei Huang Green Chem. 2021 23 8280

• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to 4-Amino-3-chlorobenzoic acid (CAS No. 2486-71-7)

4-Amino-3-chlorobenzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 2486-71-7, is a versatile organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This benzoic acid derivative features both an amino group and a chloro substituent, making it a valuable intermediate in the synthesis of various bioactive molecules. Its unique structural properties have positioned it as a key building block in the development of novel therapeutic agents, particularly those targeting inflammatory and metabolic disorders.

The significance of 4-Amino-3-chlorobenzoic acid lies in its broad applicability across multiple domains of chemical biology. The presence of both the amino and chloro functional groups allows for diverse chemical modifications, enabling researchers to tailor its properties for specific applications. In recent years, this compound has been extensively studied for its potential in drug discovery, with particular focus on its role in modulating enzymatic pathways and interactions with biological targets.

One of the most compelling aspects of 4-Amino-3-chlorobenzoic acid is its utility in the synthesis of inhibitors targeting key enzymes involved in metabolic diseases. For instance, studies have demonstrated its efficacy in the development of compounds that inhibit xanthine oxidase, an enzyme critical in the regulation of purine metabolism. The structural motif of this compound allows for precise binding to the active site of xanthine oxidase, thereby modulating its activity and potentially alleviating conditions associated with excessive oxidative stress.

Furthermore, research has highlighted the role of 4-Amino-3-chlorobenzoic acid in the design of novel anti-inflammatory agents. The benzoic acid scaffold is well-known for its pharmacological properties, and modifications such as the introduction of a chloro group at the 3-position enhance its binding affinity to inflammatory mediators. Recent studies have shown that derivatives of this compound exhibit significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. These findings underscore the potential of 4-Amino-3-chlorobenzoic acid as a lead compound in the development of therapies for chronic inflammatory diseases.

The synthetic chemistry surrounding 4-Amino-3-chlorobenzoic acid has also seen considerable advancements. Modern synthetic methodologies have enabled the efficient preparation of this compound and its derivatives, making it more accessible for industrial applications. Techniques such as palladium-catalyzed cross-coupling reactions and enzymatic resolutions have been employed to enhance yield and purity, ensuring that researchers have high-quality starting materials for their investigations.

In addition to its pharmaceutical applications, 4-Amino-3-chlorobenzoic acid has found utility in materials science and agrochemical research. Its ability to act as a precursor in the synthesis of complex organic molecules makes it a valuable reagent in these fields. For example, agrochemical companies have explored its use in developing novel herbicides and fungicides that exhibit improved efficacy and environmental compatibility.

The future prospects for 4-Amino-3-chlorobenzoic acid are promising, with ongoing research aimed at uncovering new therapeutic applications and optimizing synthetic routes. Advances in computational chemistry and high-throughput screening techniques are expected to accelerate the discovery process, enabling faster identification of lead compounds derived from this versatile intermediate.

In conclusion, 4-Amino-3-chlorobenzoic acid (CAS No. 2486-71-7) represents a critical component in modern chemical biology research. Its unique structural features and broad applicability make it an indispensable tool for pharmaceutical development, particularly in addressing metabolic and inflammatory disorders. As scientific understanding continues to evolve, it is likely that this compound will play an even more prominent role in shaping future therapeutic strategies.

• 69236-82-4(4-Chloro-3,5-diamino benzoic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)